Image

Image

Welcome to Novartis Pro
Our redesigned site is a centralised hub of information, resources and events to support you and your patients using our products and services
This page is intended for UK healthcare professionals and other relevant decision makers only. If you are a member of the public, please click here.
This portal is funded and owned by Novartis Pharmaceuticals UK Ltd and includes content approved by Novartis.
Adverse events reporting information can be found in the footer of this page.
This is your Novartis hub, newly designed to provide you, the healthcare professional, with everything you need to support you and your patients. On Novartis Pro you will find all of the existing content with the addition, in some instances, of new and updated content.
Novartis Pro contains the latest product information, resources and training materials, alongside events, webinars, formulary and service support. Everything you need to help you deliver excellent care for your patients.
Receive regular updates to your inbox with content tailored to your needs.
All the latest resources and training programs across a variety of therapy areas.
Register for events and webinars involving key opinion leaders, or watch on demand.
Interact with tailor-made content covering a wide range of topics.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.